|
Q3 FY2026
As of Sep 30, 2026
|
Q2 FY2026
As of Jun 30, 2026
|
Q1 FY2026
As of Mar 31, 2026
|
Q4 FY2025
As of Dec 31, 2025
|
Q3 FY2025
As of Sep 30, 2025
|
Q2 FY2025
As of Jun 30, 2025
|
Q1 FY2025
As of Mar 31, 2025
|
Q4 FY2024
As of Dec 31, 2024
|
Q3 FY2024
As of Sep 30, 2024
|
Q2 FY2024
As of Jun 30, 2024
|
Q1 FY2024
As of Mar 31, 2024
|
Q4 FY2023
As of Dec 31, 2023
|
Q3 FY2023
As of Sep 30, 2023
|
Q2 FY2023
As of Jun 30, 2023
|
Q1 FY2023
As of Mar 31, 2023
|
Q4 FY2022
As of Dec 31, 2022
|
Q3 FY2022
As of Sep 30, 2022
|
Q2 FY2022
As of Jun 30, 2022
|
Q1 FY2022
As of Mar 31, 2022
|
Q4 FY2021
As of Dec 31, 2021
|
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||||||||||||||
| Cash and cash equivalents | ||||||||||||||||||||
| Cash collateral posted to counterparties | ||||||||||||||||||||
| Investments in securities, at fair value | ||||||||||||||||||||
| Debt securities | ||||||||||||||||||||
| Agency Securities | ||||||||||||||||||||
| U.S. Treasury Securities | ||||||||||||||||||||
| Receivable for unsettled sales (including pledged securities of $350,147 ($158,151 with BUCKLER) at September 30, 2026) | ||||||||||||||||||||
| Derivatives, at fair value | ||||||||||||||||||||
| Accrued interest receivable | ||||||||||||||||||||
| Prepaid and other | ||||||||||||||||||||
| Total Assets | ||||||||||||||||||||
| Liabilities and Stockholders’ Equity | ||||||||||||||||||||
| Liabilities | ||||||||||||||||||||
| Repurchase agreements, net (including $9,644,292 and $8,426,540, at September 30, 2026 and December 31, 2025, respectively with BUCKLER) | ||||||||||||||||||||
| Obligations to return securities received as collateral, at fair value | ||||||||||||||||||||
| BUCKLER Securities, LLC | ||||||||||||||||||||
| Total obligations to return securities received as collateral, at fair value | ||||||||||||||||||||
| Cash collateral posted by counterparties | ||||||||||||||||||||
| Payable for unsettled purchases | ||||||||||||||||||||
| Derivatives, at fair value | ||||||||||||||||||||
| Accrued interest payable- repurchase agreements (including $29,701 and $27,752, at September 30, 2026 and December 31, 2025, respectively with BUCKLER) | ||||||||||||||||||||
| Accrued interest payable - U.S. Treasury Securities sold short | ||||||||||||||||||||
| Accounts payable and other accrued expenses | ||||||||||||||||||||
| Total Liabilities | ||||||||||||||||||||
| Stockholders’ Equity | ||||||||||||||||||||
| Preferred stock, $0.001 par value, 50,000 shares authorized; 7.00% Series C Cumulative Preferred Stock; 7,676 shares and 7,048 shares issued and outstanding ($25.00 per share liquidation preference) at September 30, 2026 and December 31, 2025, respectively | ||||||||||||||||||||
| Series C Preferred Stock | ||||||||||||||||||||
| Total preferred stock, $0.001 par value, 50,000 shares authorized; 7.00% Series C Cumulative Preferred Stock; 7,676 shares and 7,048 shares issued and outstanding ($25.00 per share liquidation preference) at September 30, 2026 and December 31, 2025, respectively | ||||||||||||||||||||
| Common stock, $0.001 par value, 250,000 and 175,000 shares authorized; 148,415 shares and 111,915 shares issued and outstanding at September 30, 2026 and December 31, 2025, respectively. | ||||||||||||||||||||
| Additional paid-in capital | ||||||||||||||||||||
| Cumulative distributions to stockholders | ||||||||||||||||||||
| Accumulated net loss | ||||||||||||||||||||
| Accumulated other comprehensive loss | ||||||||||||||||||||
| Total Stockholders’ Equity | ||||||||||||||||||||
| Total Liabilities and Stockholders’ Equity | ||||||||||||||||||||
Loading...
